Point of Care Diagnostics – Thematic Intelligence

Point of Care Diagnostics Market Thematic Overview

The predominant devices used for human immunodeficiency virus (HIV) detection are enzyme immunoassay (EIA) tests, owing to their high specificity and sensitivity as well as their ability to be adapted for high-throughput testing. POC testing of HIV attempts to address delay in detection of HIV status by providing preliminary antibody results and are therefore useful especially in resource limited. Thus, HIV POC diagnostics are expected to increase in usage due to their easy usage and lack of complex laboratory infrastructure during the forecast period.

The point of care diagnostics report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.

Trends in the Point of Care Diagnostics Market

The main trends shaping the point of care diagnostics industry are technology trends, macroeconomic trends and regulatory trends.

Technology trends: The key technology trends impacting the point of care diagnostics theme are increase in COVID-19 POC diagnostic usage, increase in HIV POC diagnostic usage, and increase in H. pylori POC diagnostic usage among others.

Macroeconomic trends: Cost effectiveness, evidence-based healthcare reimbursement, and growing prevalence of chronic diseases are some of the macroeconomic trends impacting the theme.

Regulatory trends: The key regulatory trends impacting the point of care diagnostics theme are the European medical device regulation, compliance with regulatory guidelines concerning POCT, and introduction of clinical laboratory improvement amendments (CLIA)-waived tests.

Point of Care Diagnostics - Value Chain Analysis

The POC diagnostics market can be segmented according to several indications, including applications and POC diagnostics.

Rising demand for rapid diagnostics in the healthcare sector has led to the research and development of numerous POC diagnostic devices and technologies. Researchers across the globe are studying and reporting novel techniques that have the potential to be translated into POC diagnostic devices. In the case of developing countries, there is a huge need for the POC approach, especially for the detection of infectious diseases. GlobalData expects POC diagnostics will be heavily adopted in rural areas in the next few years.

Point of Care Diagnostics, Value Chain Analysis

Buy the Report to Get More Insights on the Healthcare in Value Chain Analysis, Download a Free Report Sample

Point of Care Diagnostics - Industry Analysis

The diagnostic testing market revenue was valued at $42.78 billion in 2022. Historically the largest segment in POC diagnostics has been infectious diseases, followed by metabolic and hematological disorders, in order. This is due primarily to the wider range of available infectious disease tests and the larger population of patients in need of testing. The 2022 market segment revenues can be seen in the graph below.

The point of care diagnostics industry thematic intelligence report also covers:

• Mergers and acquisitions
• Timeline

Diagnostic Testing Market Revenue to 2028 ($B)

Buy the Report to Get More Insights on the Healthcare in Industry Analysis, Download a Free Report Sample

Point of Care Diagnostics – Competitive Landscape

The key companies making their mark in the POC diagnostics theme are as follows:

• Abbott Laboratories
• Danaher
• EFK Diagnostics
• OraSure Technologies
• Quidel

Buy the Report to Get More Insights on the Leading Public and Private Companies in the Point of Care Diagnostics Theme, Download a Free Report Sample

Medical Devices Sector Scorecard

At GlobalData, we use a scorecard approach to predict tomorrow’s leading companies within each sector. Our sector scorecard has three screens: a thematic screen, a valuation screen, and a risk screen.

• The thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
• The valuation screen ranks our universe of companies within a sector based on selected valuation metrics.

• The risk screen ranks companies within a particular sector based on overall investment risk.

Medical Devices Sector Scorecard

Buy the Full Report for more information about sector scorecards, download a free report sample

Scope

• This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
• The report covers the point of care diagnostics theme.

Reasons to Buy

• GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
• Develop and design your corporate strategies through an in-house expert analysis of healthcare by understanding the primary ways in which this theme is impacting the healthcare industry.
• Stay up to date on the industry’s major players and where they sit in the value chain.
• Identify emerging industry trends to gain a competitive advantage.